MDXG mimedx.com Net earnings per share for the last 12 months

Public company logo of MiMedx Group, Inc. (MDXG)

High margins for EpiFix and FDA approvals are driving price action, and this rolling 12-month EPS chart from the GURU.Markets terminal shows the -0.13 mark capturing this metric. While inelastic demand for regenerative medicine ensures business resilience, Medicare regulatory changes and patent disputes create significant risks for MiMedx Group, Inc. (MDXG).

MDXG (MiMedx Corp) Net earnings per share (EPS TTM) history from 07/04/2022 to 11/15/2026

Analytical breakdowns and data insights for company MiMedx Corp (MDXG)

- stock price and consensus target price:
Fundamental company valuation:MiMedx Group Inc (MDXG)
Mass-produced product of MiMedx Group

Net income per share over the last four quarters measures the actual yield of each security, allowing investors to assess capital allocation efficiency and overall business profitability. Analyzing the EPS TTM annual snapshot confirms the operational resilience of MiMedx Group, Inc., which is supported by high utilization of biopharmaceutical capacities and the planned modernization of therapeutic implant production lines.

Competitors of MiMedx Group, Inc.

Ascendis - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Madrigal Pharma|CORT (Corcept Therapeutics Incorporated) - Net earnings per share for the last 12 months|RYTM: Earnings per share for the last four quarters|AKRO (Akero Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Metsera Inc|Net earnings per share (EPS TTM) MLTX|Earnings per share for the last twelve months CRNX (Crinetics Pharmaceuticals, Inc.)|Earnings per share for the last twelve months newamsterdampharma.com NAMS|Soleno Therapeutics Corp (SLNO) - Net earnings per one share for the last twelve months|FOLD - Earnings per share for the last twelve months|ETNB: Earnings per share for the last twelve months|AGIO: Net earnings per share (EPS TTM)|GPCR - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Rezolute Bio|Lexicon Corp (LXRX) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months mbxbio.com (MBX)|Net earnings per share (EPS TTM) altimmune.com (ALT)|Net earnings per share (EPS TTM) AARD (aardvarktherapeutics.com)|Net earnings per share for the last four quarters Sagimet Biosciences Inc. (SGMT)|BioAge Labs, Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Biomea Fusion Corp BMEA|QNCX: Net earnings per share (EPS TTM)|Fractyl Health, Inc. (GUTS) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months VTVT|Agape ATP Corporation - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) PLUR|SYBX - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) LPCN (lipocine.com)|Net earnings per share (EPS TTM) Matinas BioPharma MTNB|SPRB: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months Galecto Corp|CTCX (Carmell Corp) - Net earnings per share for the last 12 months|Lumos Pharma Corp - Earnings per share for the trailing year|Net earnings per share for the last 12 months ONVO|Net earnings per one share for the last twelve months Radius Recycling, Inc. RDUS